These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3620295)

  • 1. Pharmacokinetics and renal elimination of desferrioxamine and ferrioxamine in healthy subjects and patients with haemochromatosis.
    Allain P; Mauras Y; Chaleil D; Simon P; Ang KS; Cam G; Le Mignon L; Simon M
    Br J Clin Pharmacol; 1987 Aug; 24(2):207-12. PubMed ID: 3620295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of aluminoxamine and ferrioxamine and dose finding of desferrioxamine in haemodialysis patients.
    Verpooten GA; D'Haese PC; Boelaert JR; Becaus I; Lamberts LV; De Broe ME
    Nephrol Dial Transplant; 1992; 7(9):931-8. PubMed ID: 1328941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low percentage of aluminoxamine and ferrioxamine in uremic serum after desferrioxamine administration.
    Menéndez-Fraga P; Fernández-Martín JL; Blanco-González E; Cannata-Andía JB
    Clin Chem; 1998 Jun; 44(6 Pt 1):1262-8. PubMed ID: 9625051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of desferrioxamine and of its iron and aluminum chelates in patients on peritoneal dialysis.
    Allain P; Chaleil D; Mauras Y; Varin MC; Ang KS; Cam G; Simon P
    Clin Chim Acta; 1988 Apr; 173(3):313-6. PubMed ID: 3383431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of aluminoxamine and feroxamine chelates in dialysis patients.
    Canavese C; Gurioli L; D'Amicone M; Cardelli R; Caligaris F; Bongiorno P; Arnaud A; Mattiello G; Marchiori M
    Nephron; 1992; 60(4):411-7. PubMed ID: 1584315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary and biliary excretion of aluminoxamine and ferrioxamine in dogs with various renal function.
    D'Haese PC; Lamberts LV; Verpooten GA; Vaneerdeweg W; Jurgens A; Arakelian S; Babloyan A; Digenis P; Tjalma W; De Broe ME
    Kidney Int; 1994 Jan; 45(1):76-84. PubMed ID: 8127024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies in desferrioxamine and ferrioxamine metabolism in normal and iron-loaded subjects.
    Summers MR; Jacobs A; Tudway D; Perera P; Ricketts C
    Br J Haematol; 1979 Aug; 42(4):547-55. PubMed ID: 476006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deferoxamine pharmacokinetics.
    Porter JB
    Semin Hematol; 2001 Jan; 38(1 Suppl 1):63-8. PubMed ID: 11206963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of aluminum and deferoxamine on biliary iron elimination in the rat.
    Allain P; Leblondel G; Mauras Y
    Proc Soc Exp Biol Med; 1988 Sep; 188(4):471-3. PubMed ID: 3420110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation of aluminoxamine and ferrioxamine in plasma by high performance liquid chromatography.
    Hughes H; Hagen LE; Cameron EC; Sutton RA
    Clin Chim Acta; 1986 May; 157(1):115-20. PubMed ID: 3719992
    [No Abstract]   [Full Text] [Related]  

  • 11. Removal of aluminoxamine and ferrioxamine by charcoal hemoperfusion and hemodialysis.
    Vasilakakis DM; D'Haese PC; Lamberts LV; Lemoniatou E; Digenis PN; De Broe ME
    Kidney Int; 1992 May; 41(5):1400-7. PubMed ID: 1614055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of desferrioxamine and of its iron and aluminium chelates in patients on haemodialysis.
    Allain P; Chaleil D; Mauras Y; Beaudeau G; Varin MC; Poignet JL; Ciancioni C; Ang KS; Cam G; Simon P
    Clin Chim Acta; 1987 Dec; 170(2-3):331-8. PubMed ID: 3436066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of desferrioxamine, ferrioxamine and aluminoxamine by post-column derivatization high-performance liquid chromatography. Non-linear calibration resulting from second-order reaction kinetics.
    Kraemer HJ; Breithaupt H
    J Chromatogr B Biomed Sci Appl; 1998 Jun; 710(1-2):191-204. PubMed ID: 9686887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of variations of subcutaneously infused desferrioxamine and iron movements in thalassaemia children.
    Llados i Vallory EA; Girot R; Lenoir G; Payet M; Houze P; Bourdon R
    Eur J Pediatr; 1989 Apr; 148(6):503-6. PubMed ID: 2744011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimation of statistical moments for desferrioxamine and its iron and aluminum chelates: contribution to optimisation of therapy in uremic patients.
    Andriani M; Nordio M; Saporiti E
    Nephron; 1996; 72(2):218-24. PubMed ID: 8684530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of ultrafiltration and chromatography to assess aluminum speciation in serum after deferoxamine administration.
    Canteros-Picotto A; Fernández-Martín JL; Cannata-Andía JB
    Am J Kidney Dis; 2000 Nov; 36(5):969-75. PubMed ID: 11054353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant removal of aluminium and iron by haemodialysis and haemofiltration after desferrioxamine intravenous infusion.
    Ciancioni C; Poignet JL; Naret C; Delons S; Mauras Y; Allain P; Man NK
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():469-73. PubMed ID: 3991542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chelation of transferrin iron by desferrioxamine in K562 cells. The partition of iron between ferrioxamine and ferritin.
    Roberts S; Bomford A
    Biochem J; 1988 Sep; 254(3):869-75. PubMed ID: 3196300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indirect measurement of desferrioxamine and its chelated compounds aluminoxamine and ferrioxamine by Zeeman atomic absorption spectrometry.
    D'Haese PC; Lamberts LV; De Broe ME
    Clin Chem; 1989 May; 35(5):884-7. PubMed ID: 2720988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential ferrioxamine test in haemochromatosis and liver diseases.
    Barry M; Cartei G; Sherlock S
    Gut; 1969 Sep; 10(9):697-704. PubMed ID: 5386626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.